(Total Views: 103)
Posted On: 01/03/2024 10:55:48 AM
Post# of 83
$AGIO News Article - Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia https://marketwirenews.com/news-releases/agio...86273.html
(0)
(0)
My Twitter: WhyteStocks
